overhaul 发表于 2025-4-1 03:05:40

http://reply.papertrans.cn/16/1502/150102/150102_61.png

triptans 发表于 2025-4-1 06:49:07

Gyan Prakash,Takeshi IwataDescribes basic research of potential therapeutic importance.Covers new drug therapy, gene therapy, cell therapy, tissue replacement, and artificial retina/cornea.Describes application of AI in transl

Mucosa 发表于 2025-4-1 10:19:12

http://reply.papertrans.cn/16/1502/150102/150102_63.png

Crater 发表于 2025-4-1 16:52:33

https://doi.org/10.1007/978-981-99-4436-1Translational research; Genetic eye diseases; Gene therapy; Gene editing; Tissue replacement; Stem cell; A

半身雕像 发表于 2025-4-1 21:33:44

http://reply.papertrans.cn/16/1502/150102/150102_65.png

monochromatic 发表于 2025-4-2 00:25:56

Advances in Vision Research, Volume IV978-981-99-4436-1Series ISSN 1612-3212 Series E-ISSN 2196-890X

入伍仪式 发表于 2025-4-2 05:40:33

http://reply.papertrans.cn/16/1502/150102/150102_67.png

GONG 发表于 2025-4-2 08:52:55

Conrad’s shorter fiction: 1901–1902c heterogeneity of IRD, targeted gene therapy is emerging as the main effective approach for treating the disease with many clinical trials currently underway. To maximize the benefit of these emerging therapies to patients, molecular diagnosis is the first critical step. In coordination with the Cl

Antarctic 发表于 2025-4-2 13:32:22

https://doi.org/10.1007/978-1-349-05274-5nce of IRD in Israel is estimated between 1:1000 and 1:2000 individuals. IRDs are divided into subgroups according to the mutated genes causing the disorder and/or according to the main cell type, which is damaged and does not function properly, i.e., rod-cone dystrophies, the most common example in

TIA742 发表于 2025-4-2 17:07:26

http://reply.papertrans.cn/16/1502/150102/150102_70.png
页: 1 2 3 4 5 6 [7]
查看完整版本: Titlebook: Advances in Vision Research, Volume IV; From Basic to Transl Gyan Prakash,Takeshi Iwata Book 2024 This is a U.S. government work and not un